Citations

Clear

6 citation(s) found for "Lee, Moo-Sik".

Comparison of Time Trends of Cardiovascular Disease Risk Factors and Framingham Risk Score Between Patients With and Without Acute Coronary Syndrome Undergoing Percutaneous Intervention Over the Last 17 Years: From the Mayo Clinic Percutaneous Coronary Int
Flammer, Andreas J. , Li, Jing , Lennon, Ryan J. , Delacroix, Sinny , Kim, Hyun-Soo , Lee, Moo‐Sik , Lerman, Amir

Mayo Clinic

Clinical Cardiology | December 15, 2015 | Volume: 38 | Issue: 12 | Pages: 747-756

10.1002/clc.22484 | PMID 26671071 Get It

ABSTRACTBackgroundThe objective of this study was to investigate cardiovascular disease risk factor (cvRF) profiles and compare their trends over 17 years in patients with and without acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI).HypothesisTime trends of cvRF are different between ACS and non‐ACS patients.MethodsThis study was a time‐trend analysis from 1994 to 2010 within the Mayo Clinic PCI registry. Outcome measures were incidence and prevalence of cvRF, including the Framingham Risk Score (FRS), at the time of admission for PCI.ResultsAge of non‐ACS patients was higher than that of ACS patients, and age distribution slightly shifted toward older age in both groups (P for trend <0.001). There was no difference in FRS between the 2 groups; however, 10‐year cardiovascular disease risk (%) remained higher in non‐ACS than in ACS patients, decreasing over time. Diastolic blood pressure and high‐density lipoprotein cholesterol were higher in non‐ACS patients, but total cholesterol and low‐density lipoprotein cholesterol were higher in ACS patients, with an improving trend over time. Prevalence of diabetes mellitus, hypertension, and history of hypercholesterolemia were higher in non‐ACS patients, increasing over time. Smoking did not change over time. Use of most medications increased over time in both groups.ConclusionsMost cvRFs and their time trends exhibited statistically significant differences between ACS and non‐ACS patients, except systolic blood pressure, body mass index, and history of myocardial infarction. A new risk‐factor profile assessment may be needed for stratification of PCI patients according to ACS and non‐ACS status. Clinical and public‐health interventions should consider different approaches to ACS and non‐ACS patients.
Time‐Trend Analysis on the Framingham Risk Score and Prevalence of Cardiovascular Risk Factors in Patients Undergoing Percutaneous Coronary Intervention Without Prior History of Coronary Vascular Disease Over the Last 17 Years: A Study From the Mayo Clinic
Flammer, Andreas J. , Li, Jing , Lennon, Ryan J. , Holmes, David R. , Rihal, Charanjit S. , Lee, Moo‐Sik , Singh, Mandeep , Rihal, Charanjit S. , Lerman, Amir

Mayo Clinic

Clinical Cardiology | March 20, 2014 | Volume: 37 | Issue: 7 | Pages: 408-416

10.1002/clc.22274 | PMID 24652812 Get It

ABSTRACTBackgroundThere is a paucity of data on the temporal trends of cardiovascular risk factors in patients undergoing percutaneous coronary intervention (PCI). We investigated the secular trends of risk profiles of patients undergoing PCI without prior history of cardiovascular disease (CVD).HypothesisCVD risk factors are changed over time.MethodsThis time‐trend analysis from 1994 to 2010 was performed within the Mayo Clinic PCI Registry. Outcome measures were prevalence of CVD risk factors, including the Framingham risk score (FRS), at the time of admission for PCI.ResultsDuring this period, 12,055 patients without a history of CVD (mean age, 65.0 ± 12.4 years, 67% male) underwent PCI at the Mayo Clinic. Age distribution slightly shifted toward older age (P for trend <0.05), but sex did not change over time. Despite a higher prevalence of hypertension, hypercholesterolemia, and diabetes mellitus over time, actual blood pressure and lipid profiles improved (P for trend <0.001). Over time, FRS and 10‐year CVD risk improved significantly (7.3 ± 3.2 to 6.5 ± 3.3, P for trend <0.001; and 11.0 to 9.0, P for trend <0.001, respectively). Body mass index, not included in the FRS, increased significantly (29.0 ± 5.2 to 30.1 ± 6.2 kg/m2, P for trend <0.001), whereas smoking prevalence did not change.ConclusionsThe current study demonstrates that although traditional FRS and its associated predicted 10‐year cardiovascular risk declined over time, the prevalence of risk factors increased in patients undergoing PCI. The study suggests the need for a new risk‐factor assessment in this patient population.
Sex-Related Differences in Fractional Flow Reserve–Guided Treatment
Li, Jing , Rihal, Charanjit S. , Matsuo, Yoshiki , Elrashidi, Muhamad Y. , Flammer, Andreas J. , Lee, Moo-Sik, Cassar, Andrew, Lennon, Ryan J. , Herrmann, Joerg, Bell, Malcolm R. , Holmes, David R. , Bresnahan, John F., Hua, Qi , Lerman, Lilach O. , Rihal, Charanjit S. , Herrmann, Joerg, Lerman, Amir

Mayo Clinic

Circulation: Cardiovascular Interventions | October 23, 2013 | Volume: 6 | Issue: 6 | Pages: 662-670

10.1161/circinterventions.113.000762 | PMID 24149976 Get It

Background— Sex-specific differences affect the evaluation, treatment, and prognosis of coronary artery disease. We tested the hypothesis that long-term outcomes of fractional flow reserve (FFR)–guided percutaneous coronary intervention (PCI) are different between women and men. Methods and Results— Consecutive 1090 patients, referred for PCI and undergoing FFR measurements at the Mayo Clinic between October 2002 and December 2009, were included in this registry study. Clinical events were compared between the sexes during a median follow-up of 50.9 months. Of all patients, women had higher FFR adjusted by visual coronary stenosis than men ( P =0.03). The Kaplan–Meier percent of major adverse cardiac events at 5 years was 35% in women and 38% in men ( P =0.54). Interestingly, in patients undergoing PCI with an FFR <0.75, the incidence of death or myocardial infarction was significantly higher in women than in men (hazard ratio, 2.16; 95% confidence interval, 1.04–4.51; P =0.04). Moreover, compared with patients with FFR >0.80, deferral of PCI for those with FFR between 0.75 and 0.80 was associated with an increased rate of major adverse cardiac events, particularly death or myocardial infarction in women (hazard ratio, 3.25; 95% confidence interval, 1.56–6.74; P =0.002) and revascularization in men (hazard ratio, 2.66; 95% confidence interval, 1.66–4.54; P <0.001). Conclusions— Long-term outcome differs between women and men undergoing FFR-guided PCI. Our data suggest that the sex-based treatment strategy is necessary to further optimize prognosis of patients with coronary artery disease.
The Decline Effect in Cardiovascular Medicine: Is the Effect of Cardiovascular Medicine and Stent on Cardiovascular Events Decline Over the Years?
Lee, Moo-Sik, Flammer, Andreas J. , Lerman, Amir

Mayo Clinic

Korean Circulation Journal | August 14, 2013 | Volume: 43 | Issue: 7 | Pages: 443

10.4070/kcj.2013.43.7.443 | PMID 23964290 Get It

Impact of Plaque Composition on Long-Term Clinical Outcomes in Patients with Coronary Artery Occlusive Disease
Kim, Wan Ho, Park, Hyun Woong , Song, In Girl, Yang, Dong Ju, Seo, Young Hoon , Yuk, Hyung Bin, Park, Yohan , Kwon, Taek‐Geun , Rihal, Charanjit S. , Lee, Moo-Sik, Bae, Jang‐Ho , Kim, Ki Hong , Rihal, Charanjit S. , Lerman, Amir

Mayo Clinic

Korean Circulation Journal | July 19, 2013 | Volume: 43 | Issue: 6 | Pages: 377

10.4070/kcj.2013.43.6.377 | PMID 23882286 Get It

Personalized Medicine in Cardiovascular Diseases
Flammer, Andreas J. , Lerman, Lilach O. , Lee, Moo‐Sik , Lerman, Amir

Mayo Clinic

Korean Circulation Journal | October 5, 2012 | Volume: 42 | Issue: 9 | Pages: 583

10.4070/kcj.2012.42.9.583 | PMID 23091501 Get It